查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球生物和生物醫學材料市場：按類型、材料、應用和地區劃分的評估、機會和預測（2016-2030）
市場調查報告書
商品編碼
1364043

全球生物和生物醫學材料市場：按類型、材料、應用和地區劃分的評估、機會和預測（2016-2030）

Biological and Biomedical Materials Market Assessment, By Type, By Materials, By Application, By Region, Opportunities and Forecast, 2016-2030F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 144 Pages | 商品交期: 3-5個工作天內

價格

2022年全球生物及生物醫用材料市場規模預計為402億美元，預測期內（2023-2030年）複合年增長率為10.7%，到2030年將達到907億美元。預計將達到美元。 生物醫學材料的發現使接受複雜手術的患者恢復正常功能並實現康復，徹底改變了現代醫學。 活細胞、組織、金屬、陶瓷和塑膠可以再加工成所需的模具、零件、纖維和薄膜，並且越來越多地用於生物醫學產品和設備。 由生物醫學材料製成的密封劑和貼片可加速受損組織的再生和癒合。 糖尿病潰瘍患者容易受到嚴重感染，但生物材料治療可以幫助促進癒合，同時減少不必要的敷料更換。

生物材料一般由動物、細菌、植物、真菌等生物體產生，透過生長生物細胞廣泛用於損傷治療。 根據世界衛生組織 (WHO) 2022 年 7 月發布的最新報告，約有 19.1 億人患有肌肉骨骼疾病。 日益嚴重的問題導致了對將生物醫學材料納入外科治療的巨大需求。 最近的發展包括使用生物材料生產微加工晶片和器官晶片。

本報告分析了全球生物材料和生物醫用材料市場，提供了產品概述、市場基本結構、總體市場規模趨勢展望、按細分市場和地區劃分的詳細趨勢，並提供了市場資訊調查主要企業的背景狀況、主要影響因素、概況及市場佔有率等。

目錄

第一章研究方法

第 2 章專案範圍與定義

第三章新型冠狀病毒感染（COVID-19）對全球生物及生物醫用材料市場的影響

第四章俄烏戰爭的影響

第 5 章執行摘要

第 6 章客戶的看法

  • 市場認知度與產品訊息
  • 品牌知名度與忠誠度
  • 做出購買決定時考慮的因素
  • 購買頻率
  • 購買媒介

第七章全球生物及生物醫用材料市場未來展望（2016-2030）

  • 市場規模與預測
    • 基於金額
    • 基於數量
  • 依類型
    • 生物材料
      • 微生物
      • 多醣
      • 多酚
      • 其他
    • 生物醫學材料
      • 自然
      • 合成
  • 依材質
    • 金屬
    • 陶瓷
    • 聚合物
    • 其他
  • 依用途
    • 醫療植入物
      • 膝關節置換術
      • 支架
      • 心律調節器
      • 植牙
      • 其他
    • 眼科
      • 青光眼
      • 眼腫瘤
      • 眼前節手術
      • 其他
    • 組織工程
    • 生物感測器
    • 藥物傳□□輸系統
      • 透皮給藥
      • 眼內給藥
      • 肺部輸送
      • 其他
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 南美洲
    • 亞太地區
    • 中東/非洲
  • 各公司的市佔率（%，2022 年）

第八章全球生物及生物醫用材料市場的未來前景：按地區劃分（2016-2030）

  • 北美*
    • 市場規模與預測
      • 基於金額
      • 基於數量
    • 依類型
    • 依材質
    • 依用途
    • 美國*
      • 市場規模與預測
      • 依類型
      • 依材質
      • 依用途
    • 加拿大
    • 墨西哥

為涵蓋的所有地區/國家提供每個細分市場的資訊。

  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 南美洲
    • 巴西
    • 阿根廷
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第九章供給面分析

  • 生產能力：依公司劃分
  • 產量：依公司劃分
  • 營運效率：依公司劃分
  • 主要工廠的位置（最多第 25 位）

第 10 章市場地圖（2022 年）

  • 依類型
  • 依材質
  • 依用途
  • 按地區

第十一章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析（數量/價值基礎）
  • 供應/價值鏈分析
  • PESTEL 分析
    • 政治因素
    • 經濟體系
    • 社會影響
    • 技術進步
    • 環境影響
    • 法律合規性和監管政策（包括法律當局）
  • 波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 替代產品的威脅
    • 新進入者的威脅
    • 競爭公司之間的對抗關係

第十二章市場動態

  • 生長促進因素
  • 抑製成長的因素（問題、限制）

第十三章主要公司狀況

  • 前 5 名市場領導者：競爭矩陣
  • 前 5 位市場領導者：市場收入分析（%，2022 年）
  • 併購 (M&A)/合資企業（如果適用）
  • SWOT 分析（針對 5 家進入市場的公司）
  • 專利分析（如果適用）

第14章價格分析

第 15 章個案研究

第16章主要公司展望

  • 美敦力
    • 公司概況
    • 管理人員
    • 產品/服務
    • 財務狀況（據報告）
    • 重點市場與地域分佈
    • 近期趨勢
  • Abbott
  • Johnson &Johnson
  • Philips
  • GE Healthcare
  • Becton Dickinson &Company
  • RevBio, Inc.
  • Aspect Biosystems Ltd.
  • Insomabio
  • Nurami Medical Nanofiber Technology

上面列出的公司並非按市場份額排序，並且可能會根據研究工作中獲得的資訊進行更改。

第十七章策略建議

第 18 章關於 Market Xcel、免責聲明

Product Code: MX10526

Global biological and biomedical materials market size was valued at USD 40.2 billion in 2022, which is expected to reach USD 90.7 billion in 2030, with a CAGR of 10.7% for the forecast period between 2023 and 2030. The discovery of biomedical materials has revolutionized modern medicinal treatment by restoring normal functioning and achieving healing for patients after undergoing complex surgeries. Living cells, tissues, metals, ceramics, plastics can be reengineered into desired mold and parts, fibers, and films that are progressively used in biomedical products and devices. Sealants and patches made from biomedical materials allow damaged tissue to regenerate and heal faster. Patients with diabetic ulcers are prone to severe infections, which can be treated with biomaterials, leading to healing while reducing unnecessary dressing replacements.

Biologically derived materials are generally produced from biological organisms like animals, bacteria, plants, fungi where such materials are extensively used for injury treatment proliferating biological cells. A recent report published by the World Health Organization (WHO) in July 2022 stated that approximately 1.91 billion people are suffering from musculoskeletal disorders. The rising problems led to huge requirements for biomaterials incorporated into surgical treatments. A recent development is progressively moving towards producing microfabricated chips using biomaterials, organs-on-chip.

Innovative Biomedical Material on Drug Delivery Systems Augments the Market

Biomaterials are considered a prominent asset, significantly driving the advanced drug delivery systems to facilitate surgery, implantation, and treatment of serious oral diseases such as periodontitis, peri-implantitis, and severe dental problems. Natural polymeric substances such as calcium phosphate, chitosan, and gelatin are substantially used to prepare various drug delivery systems. Biomedical materials have significant characteristics like antibacterial and anti-inflammatory effects and are potentially active in enhancing antibiotic activities in oral infections. In addition to oral delivery, biomedical materials are successively creating avenues for drug delivery through transdermal, pulmonary, ocular, and nasal routes where specific designing of biomaterials accomplishes the desired delivery actions.

In November 2022, LTS Lohmann invested USD 14 million with the Global Health Investment Corporation. Along with the successive investment in June 2022, Evonik has partnered with the United States Government by investing USD 220 million to build innovative drug delivery system for new lipid production facility for mRNA-based therapies. The huge potential of Biological and Biomedical Materials in the drug delivery systems has impeccable market opportunities to expand with the rising health sector exponentially.

Regulations Adoption with Biological and Biomedical Materials Implementation

Numerous international and country-specific standards and guidelines have been framed to regulate utilizing biological and biomedical materials. Assuring effectiveness and enabling execution, some of the recognized institutions are International Organizations for Standard guidelines, ASTM International, United States Pharmacopeial Convention, and European Conformity Marking. Several standard tests and practices are being incorporated like testing of polymeric biological materials that are extensively used in surgical implants, assessment of selected tissue effects of absorbable biomaterials for implant with respect to muscle and bones.

Polymeric Biomedical Materials are Successively Incorporated in Medical Implants and Devices

Polymeric materials are recognized as remarkable due to their important characteristics such as flexibility, ease of fabrication, as well as biocompatible nature. Combined with other materials, composites of polymeric biomaterials deliver a wide range of electrical, mechanical, chemical, and thermal behaviors. Polyvinylidene fluoride (PVDF), which is a piezoelectric polymer material, is extensively used in biomedical applications as a pressure and flow sensors.

Solvay is one of the leading providers of biological materials with different specialty polymers for implantable medical devices. Numerous implantable fields like cardiovascular, spine, and orthopedics are progressively incorporating their proprietary Solviva biomaterials, including polysulfone, polyetheretherketone, etc., and Victrex Invibio's biocompatible PEEK-OPTIMA polymers are growing alternatives for spinal fusion devices. In May 2022, Solvay launched a new growth platform focusing on renewable materials and biotechnology.

Varied Applications in Medical Implants

The advancement in medical technology has consequently led to innovative medical implant materials varying from conventional silicone to 3D-printed biomaterials. Ultra-high molecular-weight polyethylene (UHMWPE) is progressively used in all kinds of knee replacements, along with hip replacement implants. Cross-linked polyethylene (XLPE) can successfully accomplish hip implants, removing the revision surgery requirement. 3D-printed implantable materials are gaining interest with a microfluidic approach that has prominently led to leaps in the vascularization of engineering tissues. In Australia, researchers have significantly developed a 3D printing Biopen device called Biosphere that essentially enable surgeons to repair damaged bones and cartilage by generating new cells directly.

A published report estimated that biomedical materials in cardiovascular devices are worth an annual USD 37.9 billion. FDA-approved vacuum plasma spray equipment for enhancing orthopedic implant capabilities Viant, a medical device design company in April 2021, has invested around USD 8 million. In September 2022, the State Council of China invested around USD 29 billion in advanced medical facilities to incorporate new biomedical materials.

Impact of COVID-19

The outbreak of COVID-19 had a devastating impact on mankind. Some developed countries, like the United States and the United Kingdom, with advanced-equipped healthcare systems, found it difficult to combat the virus. Biomaterials, an essential element for drug delivery systems emerged to develop antivirals. With diverse applications, the biomedical materials help in enhancing COVID-19 immunotherapeutics in developing preventive vaccines, treatments for infections, and healing and regeneration of damaged tissues. Moderna announced the investment of more capital in April 2021 to increase the global supply for COVID-19 vaccine to nearly about to 3 billion doses.

Impact of Russia-Ukraine War

The invasion of Russia on Ukraine has led to unprecedented impact on various sectors witnessing deterioration of global economy, including healthcare. A project named KOROVAI, was designed for the international community to aid Ukraine with the coordination of medical material gifting. The financial sanctions on Russia by the Western countries has led to severe outcomes on Russian health care facilities as Russia imports massive number of medical devices from the United States and European countries. These imperative factors severely impacted the applications of biomedical materials in treatments. The measures adopted by significant government agencies are expected to overcome the disaster of aggression and retain the economic instability.

Key Players Landscape and Outlook

The biomedical materials market is successfully growing due to various factors, like increasing healthcare expenditure, requiring numerous healthcare facilities, technological advancements, etc. Medtronic, a leading forefront of the medical industry, has developed excellent biomedical materials for treating various serious operations. Incorporating chitogel, which is a dissolvable biomaterial comprising a unique combination of natural ingredients, as a part of chitogel endoscopic sinus surgery kit. To optimize wound healing after sinus surgery, chitogel kit assists in minimizing adhesions, preserves structural integrity, and imperatively take care after surgery. In May 2023, Medtronic acquired EOFlow Co. Ltd., which manufactures tubeless, wearable, and completely disposable insulin delivery devices registered by EOPatch. The proprietary Medtronic's Meal Detection Technology algorithm will be utilized in the EOFlow diabatic device to enhance the treatment technology for diabetic patients.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the Global Biological and Biomedical Materials Market

4. Impact of Russia-Ukraine War

5. Executive Summary

6. Voice of Customer

  • 6.1. Market Awareness and Product Information
  • 6.2. Brand Awareness and Loyalty
  • 6.3. Factors Considered in Purchase Decision
    • 6.3.1. Brand Name
    • 6.3.2. Quality
    • 6.3.3. Quantity
    • 6.3.4. Price
    • 6.3.5. Product Specification
    • 6.3.6. Application Specification
    • 6.3.7. Shelf-life
    • 6.3.8. Availability of Product
  • 6.4. Frequency of Purchase
  • 6.5. Medium of Purchase

7. Global Biological and Biomedical Materials Market Outlook, 2016-2030F

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
    • 7.1.2. By Volume
  • 7.2. By Type
    • 7.2.1. Biological
      • 7.2.1.1. Microorganisms
      • 7.2.1.2. Polysaccharides
      • 7.2.1.3. Polyphenols
      • 7.2.1.4. Others
    • 7.2.2. Biomedical
      • 7.2.2.1. Natural
      • 7.2.2.1.1. Protein-Based
      • 7.2.2.1.1.1. Gelatine
      • 7.2.2.1.1.2. Collagen
      • 7.2.2.1.1.3. Silk
      • 7.2.2.1.1.4. Fibrin
      • 7.2.2.1.2. Polysaccharide-Based
      • 7.2.2.1.2.1. Chitosan
      • 7.2.2.1.2.2. Alginate
      • 7.2.2.1.2.3. Cellulose
      • 7.2.2.2. Synthetic
      • 7.2.2.2.1. Polyurethane
      • 7.2.2.2.2. Polyethylene
      • 7.2.2.2.3. Alloys
      • 7.2.2.2.4. Others
  • 7.3. By Materials
    • 7.3.1. Metals
    • 7.3.2. Ceramics
    • 7.3.3. Polymers
    • 7.3.4. Others
  • 7.4. By Applications
    • 7.4.1. Medical Implants
      • 7.4.1.1. Knee Replacement
      • 7.4.1.2. Stent
      • 7.4.1.3. Pacemakers
      • 7.4.1.4. Dental Implants
      • 7.4.1.5. Others
    • 7.4.2. Ophthalmology
      • 7.4.2.1. Glaucoma
      • 7.4.2.2. Ocular Oncology
      • 7.4.2.3. Anterior Segment Surgery
      • 7.4.2.4. Others
    • 7.4.3. Tissues Engineering
    • 7.4.4. Biosensors
    • 7.4.5. Drug-delivery Systems
      • 7.4.5.1. Transdermal Delivery
      • 7.4.5.2. Ocular Delivery
      • 7.4.5.3. Pulmonary Delivery
      • 7.4.5.4. Others
    • 7.4.6. Others
  • 7.5. By Region
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. South America
    • 7.5.4. Asia-Pacific
    • 7.5.5. Middle East and Africa
  • 7.6. By Company Market Share (%), 2022

8. Global Biological and Biomedical Materials Market Outlook, By Region, 2016-2030F

  • 8.1. North America*
    • 8.1.1. Market Size & Forecast
      • 8.1.1.1. By Value
      • 8.1.1.2. By Volume
    • 8.1.2. By Type
      • 8.1.2.1. Biological
      • 8.1.2.1.1. Microorganisms
      • 8.1.2.1.2. Polysaccharides
      • 8.1.2.1.3. Polyphenols
      • 8.1.2.1.4. Others
      • 8.1.2.2. Biomedical
      • 8.1.2.2.1. Natural
      • 8.1.2.2.1.1. Protein-Based
      • 8.1.2.2.1.1.1. Gelatine
      • 8.1.2.2.1.1.2. Collagen
      • 8.1.2.2.1.1.3. Silk
      • 8.1.2.2.1.1.4. Fibrin
      • 8.1.2.2.1.2. Polysaccharide-Based
      • 8.1.2.2.1.2.1. Chitosan
      • 8.1.2.2.1.2.2. Alginate
      • 8.1.2.2.1.2.3. Cellulose
      • 8.1.2.2.2. Synthetic
      • 8.1.2.2.2.1. Polyurethane
      • 8.1.2.2.2.2. Polyethylene
      • 8.1.2.2.2.3. Alloys
      • 8.1.2.2.2.4. Others
    • 8.1.3. By Materials
      • 8.1.3.1. Metals
      • 8.1.3.2. Ceramics
      • 8.1.3.3. Polymers
      • 8.1.3.4. Others
    • 8.1.4. By Applications
      • 8.1.4.1. Medical Implants
      • 8.1.4.1.1. Knee Replacement
      • 8.1.4.1.2. Stent
      • 8.1.4.1.3. Pacemakers
      • 8.1.4.1.4. Dental Implants
      • 8.1.4.1.5. Others
      • 8.1.4.2. Ophthalmology
      • 8.1.4.2.1. Glaucoma
      • 8.1.4.2.2. Ocular Oncology
      • 8.1.4.2.3. Anterior Segment Surgery
      • 8.1.4.2.4. Others
      • 8.1.4.3. Tissues Engineering
      • 8.1.4.4. Biosensors
      • 8.1.4.5. Drug-delivery Systems
      • 8.1.4.5.1. Transdermal Delivery
      • 8.1.4.5.2. Ocular Delivery
      • 8.1.4.5.3. Pulmonary Delivery
      • 8.1.4.5.4. Others
      • 8.1.4.6. Others
    • 8.1.5. United States*
      • 8.1.5.1. Market Size & Forecast
      • 8.1.5.1.1. By Value
      • 8.1.5.1.2. By Volume
      • 8.1.5.2. By Type
      • 8.1.5.2.1. Biological
      • 8.1.5.2.1.1. Microorganisms
      • 8.1.5.2.1.2. Polysaccharides
      • 8.1.5.2.1.3. Polyphenols
      • 8.1.5.2.1.4. Others
      • 8.1.5.2.2. Biomedical
      • 8.1.5.2.2.1. Natural
      • 8.1.5.2.2.1.1. Protein-Based
      • 8.1.5.2.2.1.1.1. Gelatine
      • 8.1.5.2.2.1.1.2. Collagen
      • 8.1.5.2.2.1.1.3. Silk
      • 8.1.5.2.2.1.1.4. Fibrin
      • 8.1.5.2.2.1.2. Polysaccharide-Based
      • 8.1.5.2.2.1.2.1. Chitosan
      • 8.1.5.2.2.1.2.2. Alginate
      • 8.1.5.2.2.1.2.3. Cellulose
      • 8.1.5.2.2.2. Synthetic
      • 8.1.5.2.2.2.1. Polyurethane
      • 8.1.5.2.2.2.2. Polyethylene
      • 8.1.5.2.2.2.3. Alloys
      • 8.1.5.2.2.2.4. Others
      • 8.1.5.3. By Materials
      • 8.1.5.3.1. Metals
      • 8.1.5.3.2. Ceramics
      • 8.1.5.3.3. Polymers
      • 8.1.5.3.4. Others
      • 8.1.5.4. By Applications
      • 8.1.5.4.1. Medical Implants
      • 8.1.5.4.1.1. Knee Replacement
      • 8.1.5.4.1.2. Stent
      • 8.1.5.4.1.3. Pacemakers
      • 8.1.5.4.1.4. Dental Implants
      • 8.1.5.4.1.5. Others
      • 8.1.5.4.2. Ophthalmology
      • 8.1.5.4.2.1. Glaucoma
      • 8.1.5.4.2.2. Ocular Oncology
      • 8.1.5.4.2.3. Anterior Segment Surgery
      • 8.1.5.4.2.4. Others
      • 8.1.5.4.3. Tissues Engineering
      • 8.1.5.4.4. Biosensors
      • 8.1.5.4.5. Drug-delivery Systems
      • 8.1.5.4.5.1. Transdermal Delivery
      • 8.1.5.4.5.2. Ocular Delivery
      • 8.1.5.4.5.3. Pulmonary Delivery
      • 8.1.5.4.5.4. Others
      • 8.1.5.4.6. Others
    • 8.1.6. Canada
    • 8.1.7. Mexico

All segments will be provided for all regions and countries covered:

  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. Italy
    • 8.2.4. United Kingdom
    • 8.2.5. Russia
    • 8.2.6. Netherlands
    • 8.2.7. Spain
    • 8.2.8. Turkey
    • 8.2.9. Poland
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
  • 8.4. Asia-Pacific
    • 8.4.1. India
    • 8.4.2. China
    • 8.4.3. Japan
    • 8.4.4. Australia
    • 8.4.5. Vietnam
    • 8.4.6. South Korea
    • 8.4.7. Indonesia
    • 8.4.8. Philippines
  • 8.5. Middle East & Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. South Africa

9. Supply Side Analysis

  • 9.1. Capacity, By Company
  • 9.2. Production, By Company
  • 9.3. Operating Efficiency, By Company
  • 9.4. Key Plant Locations (Up to 25)

10. Market Mapping, 2022

  • 10.1. By Types
  • 10.2. By Materials
  • 10.3. By Applications
  • 10.4. By Region

11. Macro Environment and Industry Structure

  • 11.1. Supply Demand Analysis
  • 11.2. Import Export Analysis - Volume and Value
  • 11.3. Supply/Value Chain Analysis
  • 11.4. PESTEL Analysis
    • 11.4.1. Political Factors
    • 11.4.2. Economic System
    • 11.4.3. Social Implications
    • 11.4.4. Technological Advancements
    • 11.4.5. Environmental Impacts
    • 11.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 11.5. Porter's Five Forces Analysis
    • 11.5.1. Supplier Power
    • 11.5.2. Buyer Power
    • 11.5.3. Substitution Threat
    • 11.5.4. Threat from New Entrant
    • 11.5.5. Competitive Rivalry

12. Market Dynamics

  • 12.1. Growth Drivers
  • 12.2. Growth Inhibitors (Challenges, Restraints)

13. Key Players Landscape

  • 13.1. Competition Matrix of Top Five Market Leaders
  • 13.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
  • 13.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 13.4. SWOT Analysis (For Five Market Players)
  • 13.5. Patent Analysis (If Applicable)

14. Pricing Analysis

15. Case Studies

16. Key Players Outlook

  • 16.1. Medtronic
    • 16.1.1. Company Details
    • 16.1.2. Key Management Personnel
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As reported)
    • 16.1.5. Key Market Focus & Geographical Presence
    • 16.1.6. Recent Developments
  • 16.2. Abbott
  • 16.3. Johnson & Johnson
  • 16.4. Philips
  • 16.5. GE Healthcare
  • 16.6. Becton Dickinson & Company
  • 16.7. RevBio, Inc.
  • 16.8. Aspect Biosystems Ltd.
  • 16.9. Insomabio
  • 16.10. Nurami Medical Nanofiber Technology

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 2. Global Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 3. Global Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 4. Global Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 5. Global Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 6. Global Biological and Biomedical Materials Market Share, By Region, in USD Billion, 2016-2030F
  • Figure 7. North America Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 8. North America Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 9. North America Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 10. North America Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 11. North America Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 12. North America Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 13. United States Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 14. United States Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 15. United States Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 16. United States Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 17. United States Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 18. Canada Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 19. Canada Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 20. Canada Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 21. Canada Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 22. Canada Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 23. Mexico Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 24. Mexico Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 25. Mexico Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 26. Mexico Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 27. Mexico Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 28. Europe Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 29. Europe Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 30. Europe Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 31. Europe Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 32. Europe Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 33. Europe Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 34. Germany Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 35. Germany Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 36. Germany Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 37. Germany Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 38. Germany Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 39. France Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 40. France Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 41. France Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 42. France Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 43. France Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 44. Italy Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 45. Italy Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 46. Italy Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 47. Italy Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 48. Italy Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 49. United Kingdom Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 50. United Kingdom Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 51. United Kingdom Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 52. United Kingdom Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 53. United Kingdom Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 54. Russia Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 55. Russia Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 56. Russia Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 57. Russia Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 58. Russia Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 59. Netherlands Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 60. Netherlands Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 61. Netherlands Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 62. Netherlands Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 63. Netherlands Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 64. Spain Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 65. Spain Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 66. Spain Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 67. Spain Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 68. Spain Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 69. Turkey Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 70. Turkey Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 71. Turkey Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 72. Turkey Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 73. Turkey Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 74. Poland Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 75. Poland Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 76. Poland Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 77. Poland Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 78. Poland Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 79. South America Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 80. South America Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 81. South America Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 82. South America Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 83. South America Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 84. South America Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 85. Brazil Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 86. Brazil Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 87. Brazil Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 88. Brazil Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 89. Brazil Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 90. Argentina Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 91. Argentina Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 92. Argentina Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 93. Argentina Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 94. Argentina Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 95. Asia-Pacific Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 96. Asia-Pacific Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 97. Asia-Pacific Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 98. Asia-Pacific Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 99. Asia-Pacific Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 100. Asia-Pacific Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 101. India Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 102. India Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 103. India Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 104. India Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 105. India Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 106. China Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 107. China Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 108. China Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 109. China Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 110. China Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 111. Japan Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 112. Japan Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 113. Japan Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 114. Japan Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 115. Japan Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 116. Australia Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 117. Australia Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 118. Australia Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 119. Australia Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 120. Australia Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 121. Vietnam Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 122. Vietnam Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 123. Vietnam Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 124. Vietnam Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 125. Vietnam Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 126. South Korea Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 127. South Korea Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 128. South Korea Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 129. South Korea Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 130. South Korea Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 131. Indonesia Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 132. Indonesia Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 133. Indonesia Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 134. Indonesia Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 135. Indonesia Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 136. Philippines Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 137. Philippines Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 138. Philippines Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 139. Philippines Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 140. Philippines Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 141. Middle East & Africa Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 142. Middle East & Africa Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 143. Middle East & Africa Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 144. Middle East & Africa Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 145. Middle East & Africa Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 146. Middle East & Africa Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 147. Saudi Arabia Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 148. Saudi Arabia Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 149. Saudi Arabia Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 150. Saudi Arabia Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 151. Saudi Arabia Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 152. UAE Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 153. UAE Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 154. UAE Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 155. UAE Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 156. UAE Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 157. South Africa Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 158. South Africa Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 159. South Africa Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 160. South Africa Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 161. South Africa Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 162. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 163. By Materials Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022